Limits...
Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression.

Huntley JD, Gould RL, Liu K, Smith M, Howard RJ - BMJ Open (2015)

Bottom Line: Significant benefit was also seen with the Alzheimer's disease Assessment Scale-Cognition (ADAS-Cog) (g=-0.26, 95% CI -0.445 to -0.08; p=0.005).There was no evidence that CT or MCTS produced significant improvements on general cognition outcomes and not enough CR studies for meta-analysis.Additionally, 95% prediction intervals suggested that although statistically significant, CS may not lead to benefits on the ADAS-Cog in all clinical settings.

View Article: PubMed Central - PubMed

Affiliation: Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Show MeSH

Related in: MedlinePlus

Forest Plot of CS versus active controls-MMSE outcome. CS, cognitive stimulation; MMSE, mini-mental state examination.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC4390716&req=5

BMJOPEN2014005247F3: Forest Plot of CS versus active controls-MMSE outcome. CS, cognitive stimulation; MMSE, mini-mental state examination.

Mentions: A smaller but still significant pooled effect size of 0.35 (95% CI 0.06 to 0.64; z=2.34, p=0.019) was found for CS versus active controls on the MMSE (figure 3), with no heterogeneity between the three studies (I2=0.0%).


Do cognitive interventions improve general cognition in dementia? A meta-analysis and meta-regression.

Huntley JD, Gould RL, Liu K, Smith M, Howard RJ - BMJ Open (2015)

Forest Plot of CS versus active controls-MMSE outcome. CS, cognitive stimulation; MMSE, mini-mental state examination.
© Copyright Policy - open-access
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC4390716&req=5

BMJOPEN2014005247F3: Forest Plot of CS versus active controls-MMSE outcome. CS, cognitive stimulation; MMSE, mini-mental state examination.
Mentions: A smaller but still significant pooled effect size of 0.35 (95% CI 0.06 to 0.64; z=2.34, p=0.019) was found for CS versus active controls on the MMSE (figure 3), with no heterogeneity between the three studies (I2=0.0%).

Bottom Line: Significant benefit was also seen with the Alzheimer's disease Assessment Scale-Cognition (ADAS-Cog) (g=-0.26, 95% CI -0.445 to -0.08; p=0.005).There was no evidence that CT or MCTS produced significant improvements on general cognition outcomes and not enough CR studies for meta-analysis.Additionally, 95% prediction intervals suggested that although statistically significant, CS may not lead to benefits on the ADAS-Cog in all clinical settings.

View Article: PubMed Central - PubMed

Affiliation: Department of Old Age Psychiatry, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.

Show MeSH
Related in: MedlinePlus